Cancer incidence continues rising across Asia-Pacific and Africa, with the Philippines, South Africa, Australia, and Singapore facing growing demand for affordable, WHO-approved oncology medicines. Unnati Pharmax supplies a comprehensive range of generic cancer medicines to all four markets at significantly reduced cost.
In Manila, Cebu, and Davao in the Philippines, blood cancers and platelet disorders remain significant health challenges, with Philippine General Hospital and provincial centres actively sourcing affordable Indian generics. In South Africa, prostate cancer is the most commonly diagnosed cancer in men, with rising incidence across Johannesburg, Cape Town, and Durban driving demand for affordable Abiraterone. In Sydney, Melbourne, and Singapore, private oncology patients increasingly source Indian generics to reduce out-of-pocket treatment costs significantly.
Unnati Pharmax supplies Eltrombopag, Abiraterone, Imatinib, Lenalidomide, and Bortezomib to all four markets via DHL/FedEx with full documentation. Visit medshopy.com or WhatsApp +91 82650 41513 for international pricing.
In Manila, Cebu, and Davao in the Philippines, blood cancers and platelet disorders remain significant health challenges, with Philippine General Hospital and provincial centres actively sourcing affordable Indian generics. In South Africa, prostate cancer is the most commonly diagnosed cancer in men, with rising incidence across Johannesburg, Cape Town, and Durban driving demand for affordable Abiraterone. In Sydney, Melbourne, and Singapore, private oncology patients increasingly source Indian generics to reduce out-of-pocket treatment costs significantly.
Unnati Pharmax supplies Eltrombopag, Abiraterone, Imatinib, Lenalidomide, and Bortezomib to all four markets via DHL/FedEx with full documentation. Visit medshopy.com or WhatsApp +91 82650 41513 for international pricing.